Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
#2PRI RANKED
Most Cited Paper
in Heart Failure Treatment and Management
18 Months Post-Publication
Class of 2026
“Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
finerenone · Mineralocorticoid receptor antagonists · Heart failure with mildly reduced ejection fraction · Heart failure with preserved ejection fraction · Ejection fraction ≥40% · Worsening heart failure events · Cardiovascular mortality · composite primary outcome · Heart failure hospitalization · Urgent heart failure visit · Hyperkalemia · hypokalemia · Mineralocorticoid receptor antagonists · FINEARTS-HF trial · Double-blind randomized controlled trial · rate ratio
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Heart Failure Treatment and Management Papers, Class of 2026. https://pri.pepkio.com/top-papers/heart-failure-treatment-and-management/2026. Accessed 2026-08-20. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459